Literature DB >> 18502278

Intensive insulin therapy in newly diagnosed type 2 diabetes.

Ravi Retnakaran1, Daniel J Drucker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502278     DOI: 10.1016/S0140-6736(08)60736-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  20 in total

1.  Potential efficacy of Lactobacillus casei IBRC_M10711 on expression and activity of insulin degrading enzyme but not insulin degradation.

Authors:  Nadia Neyazi; Taiebeh Mohammadi Farsani; Zahra Nouri; Mohammad Hossein Ghahremani; Mohammad Reza Khorramizadeh; Roksana Tajerian; Elahe Motevaseli
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-08-29       Impact factor: 2.416

Review 2.  Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes.

Authors:  Toshikazu Yamanouchi
Journal:  Vasc Health Risk Manag       Date:  2010-04-15

3.  The effect of early insulin therapy on pancreatic β-cell function and long-term glycemic control in newly diagnosed type 2 diabetic patients.

Authors:  Suk Chon; Seungjoon Oh; Sung Woon Kim; Jin-Woo Kim; Young Seol Kim; Jeong-taek Woo
Journal:  Korean J Intern Med       Date:  2010-08-31       Impact factor: 3.165

Review 4.  Pro's and con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation.

Authors:  Mayer B Davidson
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-04       Impact factor: 3.243

Review 5.  Clinical evidence for the earlier initiation of insulin therapy in type 2 diabetes.

Authors:  David R Owens
Journal:  Diabetes Technol Ther       Date:  2013-06-20       Impact factor: 6.118

6.  How do we continue treatment in patients with type 2 diabetes when therapeutic goals are not reached with oral antidiabetes agents and lifestyle? Incretin versus insulin treatment.

Authors:  Baptist Gallwitz; Reinhard G Bretzel
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

7.  Efficacy of initial Basal-supported oral therapy with sitagliptin in untreated type 2 diabetes.

Authors:  Keiji Yoshioka
Journal:  Diabetes Ther       Date:  2013-10-15       Impact factor: 2.945

Review 8.  Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials.

Authors:  Markolf Hanefeld; Louis Monnier; Oliver Schnell; David Owens
Journal:  Diabetes Ther       Date:  2016-02-10       Impact factor: 2.945

9.  Possible role of interleukin-1β in type 2 diabetes onset and implications for anti-inflammatory therapy strategies.

Authors:  Gang Zhao; Gitanjali Dharmadhikari; Kathrin Maedler; Michael Meyer-Hermann
Journal:  PLoS Comput Biol       Date:  2014-08-28       Impact factor: 4.475

10.  Blood Glucose Fluctuations in Type 2 Diabetes Patients Treated with Multiple Daily Injections.

Authors:  Feng-Fei Li; Li-Yuan Fu; Wen-Li Zhang; Xiao-Fei Su; Jin-Dan Wu; Jin Sun; Lei Ye; Jian-Hua Ma
Journal:  J Diabetes Res       Date:  2015-12-29       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.